https://doi.org/10.1016/j.xcrm.2023.101206
X
Xiangyu Pan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
1.8K
Citations
19
h-index
26
i10-index
Xiangyu Pan is an academic researcher from Nanjing Tech University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Single-cell and spatial transcriptomics & Cancer, Hypoxia, and Metabolism. The author has an h-index of 19, co-authored 56 publications.
ORCID: 0000-0002-2537-6616Papers by this author
worksAblation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity
2023 · Cell Reports Medicine · 46 citations
Epigenetic drug library screening identified an LSD1 inhibitor to target UTX-deficient cells for differentiation therapy
2019 · Signal Transduction and Targeted Therapy · 22 citations
https://doi.org/10.1038/s41392-019-0040-2
COX-2/PGE2 upregulation contributes to the chromosome 17p-deleted lymphoma
2023 · Oncogenesis · 10 citations
https://doi.org/10.1038/s41389-023-00451-9
Acquired resistance to immunotherapy by physical barriers with cancer cell–expressing collagens in non–small cell lung cancer
2025 · Proceedings of the National Academy of Sciences · 7 citations
https://doi.org/10.1073/pnas.2500019122
Correction: Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine
2022 · Signal Transduction and Targeted Therapy · 6 citations
https://doi.org/10.1038/s41392-021-00862-3
A platform of functional studies of ESCC-associated gene mutations identifies the roles of TGFBR2 in ESCC progression and metastasis
2024 · Cell Reports · 5 citations
https://doi.org/10.1016/j.celrep.2024.114952
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat